Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP263677.RALHLFItZ0TLq82dGcnIrDeUVSvYtTw4UGlZ2btfL-iJY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP263677.RALHLFItZ0TLq82dGcnIrDeUVSvYtTw4UGlZ2btfL-iJY130_assertion type Assertion NP263677.RALHLFItZ0TLq82dGcnIrDeUVSvYtTw4UGlZ2btfL-iJY130_head.
- NP263677.RALHLFItZ0TLq82dGcnIrDeUVSvYtTw4UGlZ2btfL-iJY130_assertion description "[Overall, identification of metastatic thyroid cancer was better associated with Tg mRNA than with NIS mRNA, sTg, or whole body scan (83% vs. 16.6% vs. 50% vs. 50%; P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP263677.RALHLFItZ0TLq82dGcnIrDeUVSvYtTw4UGlZ2btfL-iJY130_provenance.
- NP263677.RALHLFItZ0TLq82dGcnIrDeUVSvYtTw4UGlZ2btfL-iJY130_assertion evidence source_evidence_literature NP263677.RALHLFItZ0TLq82dGcnIrDeUVSvYtTw4UGlZ2btfL-iJY130_provenance.
- NP263677.RALHLFItZ0TLq82dGcnIrDeUVSvYtTw4UGlZ2btfL-iJY130_assertion SIO_000772 11061512 NP263677.RALHLFItZ0TLq82dGcnIrDeUVSvYtTw4UGlZ2btfL-iJY130_provenance.
- NP263677.RALHLFItZ0TLq82dGcnIrDeUVSvYtTw4UGlZ2btfL-iJY130_assertion wasDerivedFrom befree-20140225 NP263677.RALHLFItZ0TLq82dGcnIrDeUVSvYtTw4UGlZ2btfL-iJY130_provenance.
- NP263677.RALHLFItZ0TLq82dGcnIrDeUVSvYtTw4UGlZ2btfL-iJY130_assertion wasGeneratedBy ECO_0000203 NP263677.RALHLFItZ0TLq82dGcnIrDeUVSvYtTw4UGlZ2btfL-iJY130_provenance.